PF-04957325
≥99%
- Product Code: 101936
CAS:
1305115-80-3
| Molecular Weight: | 400.38 g./mol | Molecular Formula: | C₁₄H₁₅F₃N₈OS |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
PF-04957325 is primarily investigated for its potential therapeutic applications in the field of neuroscience, particularly in the treatment of neurological and psychiatric disorders. It acts as a selective positive allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5), which plays a crucial role in synaptic plasticity and neural communication. By modulating this receptor, it may help regulate abnormal neural activity associated with conditions such as schizophrenia, anxiety, and Fragile X syndrome. Research suggests that it could offer a novel approach to managing symptoms by enhancing glutamate signaling in a targeted manner, potentially improving cognitive and behavioral outcomes. Its development highlights the growing interest in allosteric modulation as a strategy for treating complex brain disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿15,390.00 |
+
-
|
| 0.005 | 10-20 days | ฿35,910.00 |
+
-
|
PF-04957325
PF-04957325 is primarily investigated for its potential therapeutic applications in the field of neuroscience, particularly in the treatment of neurological and psychiatric disorders. It acts as a selective positive allosteric modulator of the metabotropic glutamate receptor subtype 5 (mGluR5), which plays a crucial role in synaptic plasticity and neural communication. By modulating this receptor, it may help regulate abnormal neural activity associated with conditions such as schizophrenia, anxiety, and Fragile X syndrome. Research suggests that it could offer a novel approach to managing symptoms by enhancing glutamate signaling in a targeted manner, potentially improving cognitive and behavioral outcomes. Its development highlights the growing interest in allosteric modulation as a strategy for treating complex brain disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :